TORL BioTherapeutics closed an oversubscribed $158M Series B-2 financing round to advance clinical development of its novel antibody-drug conjugate oncology pipeline.
Amount Raised
$158 Million
Round Type
Series B
Culver CityBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
TORL BioTherapeutics has closed an oversubscribed $158M Series B-2 financing round, with the proceeds intended for advancing the clinical development of its novel antibody-drug conjugate oncology pipeline.
Quick answer
TORL BioTherapeutics raised $158 Million in a Series B round, dated April 10, 2024. TORL BioTherapeutics is based in Culver City, California, United States.
- How much did TORL BioTherapeutics raise?
- TORL BioTherapeutics raised $158 Million in a Series B round on April 10, 2024.
- What does TORL BioTherapeutics do?
- TORL BioTherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer..
- Where is TORL BioTherapeutics based and how big is it?
- TORL BioTherapeutics is based in Culver City, California, United States. Fundz records about 63 employees.
- Who are the decision-makers at TORL BioTherapeutics?
- Fundz holds 3 contacts at TORL BioTherapeutics, including the Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as TORL BioTherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- vTv Therapeutics Inc. raised $51M on February 27, 2024.
- Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
Who to call at TORL BioTherapeutics, and when
A new round usually means TORL BioTherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TORL BioTherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TORL BioTherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TORL BioTherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TORL BioTherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTORL BioTherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.